InMode Total Operating Expenses Over Time
| INMD Stock | USD 19.49 0.24 1.25% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out InMode Performance and InMode Correlation. InMode |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMode. If investors know InMode will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMode listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.204 | Earnings Share 1.83 | Revenue Per Share 5.148 | Quarterly Revenue Growth 0.058 | Return On Assets 0.105 |
The market value of InMode is measured differently than its book value, which is the value of InMode that is recorded on the company's balance sheet. Investors also form their own opinion of InMode's value that differs from its market value or its book value, called intrinsic value, which is InMode's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMode's market value can be influenced by many factors that don't directly affect InMode's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMode's value and its price as these two are different measures arrived at by different means. Investors typically determine if InMode is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMode's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Operating Expenses Analysis
Compare InMode and related stocks such as TransMedics Group, Inspire Medical Systems, and Inari Medical Total Operating Expenses Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMDX | 18.2 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 22.6 M | 26 M | 43.5 M | 43 M | 60.6 M | 96.7 M | 182.8 M | 192 M |
| INSP | 25 M | 25 M | 25 M | 25 M | 25 M | 25 M | 29.8 M | 38.6 M | 60.9 M | 103.3 M | 154 M | 240 M | 389.3 M | 568.5 M | 596.9 M |
| NARI | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 44.4 M | 108.1 M | 241.4 M | 367.1 M | 448.6 M | 224.5 M |
| PODD | 12.7 M | 109.2 M | 128.3 M | 141.5 M | 155.6 M | 182 M | 221.8 M | 284.6 M | 342.7 M | 430.3 M | 530.8 M | 626.1 M | 768 M | 939.9 M | 986.9 M |
| DXCM | 4 M | 80.7 M | 102.3 M | 129 M | 197.8 M | 335.5 M | 442.3 M | 534.6 M | 850.2 M | 789.2 M | 980.6 M | 1.4 B | 1.5 B | 1.7 B | 1.8 B |
| EW | 322 M | 888.7 M | 996.6 M | 1.1 B | 1.2 B | 1.2 B | 1.3 B | 1.5 B | 1.7 B | 2 B | 2 B | 2.4 B | 2.5 B | 2.9 B | 3 B |
| SYK | 39.6 M | 3.7 B | 4.1 B | 4.7 B | 5.1 B | 4.4 B | 5.2 B | 5.7 B | 6.4 B | 6.8 B | 6.8 B | 8.3 B | 8.5 B | 9.2 B | 9.7 B |
| BSX | 81.1 M | 3.3 B | 3.8 B | 3.9 B | 4.2 B | 4.2 B | 4.6 B | 4.9 B | 5.3 B | 5.8 B | 5.7 B | 6.3 B | 6.6 B | 7.6 B | 7.9 B |
| ABT | 1.1 B | 17.6 B | 16.4 B | 9.2 B | 8.4 B | 8.8 B | 8.6 B | 13.3 B | 14.2 B | 14.1 B | 14.2 B | 16.1 B | 16.1 B | 15.7 B | 8.6 B |
| MDT | 209 M | 7.9 B | 7.7 B | 7.9 B | 9.4 B | 13.7 B | 14.1 B | 14.6 B | 14.8 B | 14.3 B | 14.7 B | 15.6 B | 14.7 B | 16.1 B | 16.9 B |
| ZBH | 385 M | 2.2 B | 2 B | 2 B | 2 B | 2.9 B | 3.9 B | 3.9 B | 4.5 B | 4.5 B | 4.2 B | 3.9 B | 3.7 B | 4 B | 2.5 B |
| TNDM | 24.2 M | 24.2 M | 31.7 M | 55.6 M | 90.9 M | 95.6 M | 101.6 M | 107 M | 134.5 M | 210.9 M | 268.5 M | 353.6 M | 474.8 M | 600.9 M | 631 M |
| ALGN | 13.4 M | 270.9 M | 294.2 M | 336.9 M | 384.9 M | 451.5 M | 566.4 M | 763.3 M | 981.3 M | 1.2 B | 1.4 B | 2 B | 2 B | 2.1 B | 2.2 B |
InMode and related stocks such as TransMedics Group, Inspire Medical Systems, and Inari Medical Total Operating Expenses description
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.My Equities
My Current Equities and Potential Positions
| InMode | INMD |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Israel |
| Exchange | NASDAQ Exchange |
USD 19.49
Check out InMode Performance and InMode Correlation. For information on how to trade InMode Stock refer to our How to Trade InMode Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
InMode technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.